Terms: = Gastric cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Prognosis
6 results:
1. The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts.
Zhong Y; Deng L; Shi S; Huang QY; Ou-Yang SM; Mo JS; Zhu K; Qu XM; Liu PQ; Wang YX; Zhang XL
Acta Pharmacol Sin; 2022 Apr; 43(4):1013-1023. PubMed ID: 34267347
[TBL] [Abstract] [Full Text] [Related]
2. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
[TBL] [Abstract] [Full Text] [Related]
3. Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line.
Xu Y; Feng S; Niu B
Biotech Histochem; 2021 Jan; 96(1):76-81. PubMed ID: 32619110
[TBL] [Abstract] [Full Text] [Related]
4. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/stat5 signaling in gastric cancer.
Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
[TBL] [Abstract] [Full Text] [Related]
5. Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer.
Xiong H; Du W; Wang JL; Wang YC; Tang JT; Hong J; Fang JY
J Mol Med (Berl); 2012 Sep; 90(9):1037-46. PubMed ID: 22328012
[TBL] [Abstract] [Full Text] [Related]
6. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract] [Full Text] [Related]
